{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:45:45Z","timestamp":1787982345170,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protoplasma"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00709-025-02096-4","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T23:26:29Z","timestamp":1753658789000},"page":"169-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model: a study using histological, molecular, and pathological parameters"],"prefix":"10.1007","volume":"263","author":[{"given":"Reem Hasaballah","family":"Alhasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifat","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishah E.","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad Eid","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair M.","family":"Mohammedsaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Barnawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashmiah S.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen S.","family":"Basoudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahlah M.","family":"Ghouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailah M.","family":"Almohaimeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabinda","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan Abd","family":"Ellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona H.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"2096_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association (2019) Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142019. Diabetes Care 42(Supplement 1):S13\u2013S28. https:\/\/doi.org\/10.2337\/dc19-S002","DOI":"10.2337\/dc19-S002"},{"key":"2096_CR2","doi-asserted-by":"publisher","unstructured":"American Diabetes Association (2023) Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care 46 (Supplement_1):S19\u2013S40. https:\/\/doi.org\/10.2337\/dc23-S002","DOI":"10.2337\/dc23-S002"},{"key":"2096_CR3","unstructured":"Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, \u2026 Shankhwar SN (2018) Withania somnifera improves hepatic and renal functions in type 2 diabetic rats: involvement of oxidative stress and inflammation. J Ethnopharmacol 214:279\u2013290"},{"key":"2096_CR4","doi-asserted-by":"crossref","unstructured":"Betteridge\u00a0DJ (2000) What is oxidative stress? Metabolism 49(2):3\u20138","DOI":"10.1016\/S0026-0495(00)80077-3"},{"key":"2096_CR5","doi-asserted-by":"publisher","first-page":"5953685","DOI":"10.1155\/2019\/5953685","volume":"2019","author":"E Bigagli","year":"2019","unstructured":"Bigagli E, Lodovici M (2019) Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications. Oxidative Med. Cell. Longev. 2019:5953685. https:\/\/doi.org\/10.1155\/2019\/5953685","journal-title":"Oxidative Med Cell Longev"},{"key":"2096_CR6","doi-asserted-by":"publisher","unstructured":"Bhat AH, Dar S, Ansari A (2021) Withania somnifera: an insight into the mechanisms of its action in diabetes and related complications. Front Pharmacol 12:770100. https:\/\/doi.org\/10.3389\/fphar.2021.770100","DOI":"10.3389\/fphar.2021.770100"},{"key":"2096_CR7","unstructured":"Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S (2001) Effect of Withania Somnifera glycowithanolides on iron-induced hepatotoxicity in rats. Phytother Res 15(6):544\u2013548"},{"issue":"2","key":"2096_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11(2):98\u2013107. https:\/\/doi.org\/10.1038\/nri2925","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2096_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82(1):70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"2096_CR10","unstructured":"Gupta R, Kaur G (2017) Withania somnifera as a potential neuroprotective agent: a review on its antioxidant, anti-inflammatory, and immunomodulatory effects. J Complement Integr Med 14(3):1\u201311"},{"key":"2096_CR11","doi-asserted-by":"publisher","first-page":"153297","DOI":"10.1016\/j.phymed.2020.153297","volume":"78","author":"S Gupta","year":"2020","unstructured":"Gupta S, Sharma A, Jain R (2020) Ashwagandha (Withania somnifera) and its role in chronic disease prevention: a molecular perspective. Phytomedicine 78:153297. https:\/\/doi.org\/10.1016\/j.phymed.2020.153297","journal-title":"Phytomedicine"},{"key":"2096_CR12","doi-asserted-by":"publisher","unstructured":"Hostalek U\u00a0(2019) Global epidemiology of prediabetes - present and future perspectives. Clin Diabetes Endocrinol 5(1). https:\/\/doi.org\/10.1186\/s40842-019-0080-0","DOI":"10.1186\/s40842-019-0080-0"},{"key":"2096_CR13","unstructured":"Kaushik MK, Kaur G, Bhatnagar P (2017) Effects of Withania somnifera root extract on pancreatic beta-cell function in diabetic rats. J Med Food 20(7):678\u2013685"},{"key":"2096_CR14","unstructured":"Kumar P, Kale RK, Baquer NZ (2011) Antidiabetic and anti-oxidative effects of Withania somnifera root extract in type 2 diabetic rats. J Pharm Pharmacol 63(2):259\u2013267"},{"issue":"2\u20133","key":"2096_CR15","first-page":"91","volume":"23","author":"G Kaur","year":"2015","unstructured":"Kaur G, Dhanjal B, Bansal S, Silakari JS (2015) Anti-inflammatory role of natural compounds in type 2 diabetes mellitus: a mechanistic insight. Inflammopharmacology 23(2\u20133):91\u2013112","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2096_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur M, Singh J (2018) Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovascular Diabetology 17(1):121","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2096_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jep.2012.05.019","volume":"142","author":"S Khan","year":"2012","unstructured":"Khan S, Mishra SK, Ahmad S, Gupta A (2012) Effect of Withania somnifera on insulin sensitivity in Non-Insulin-Dependent Diabetes Mellitus (NIDDM): a randomized, placebo-controlled trial. Journal of Ethnopharmacology 142(3):488\u2013494. https:\/\/doi.org\/10.1016\/j.jep.2012.05.019","journal-title":"J Ethnopharmacol"},{"key":"2096_CR18","doi-asserted-by":"publisher","unstructured":"Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A\u00a0(2021) Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol 42. https:\/\/doi.org\/10.1016\/j.redox.2021.101887","DOI":"10.1016\/j.redox.2021.101887"},{"issue":"2","key":"2096_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s13410-019-00772-3","volume":"40","author":"SK Kulkarni","year":"2020","unstructured":"Kulkarni SK, Dhir A, Akula KK (2020) Potential medicinal plants for anti-diabetic therapy: an updated review. International Journal of Diabetes in Developing Countries 40(2):238\u2013245. https:\/\/doi.org\/10.1007\/s13410-019-00772-3","journal-title":"Int J Diabetes Dev Countries"},{"key":"2096_CR20","doi-asserted-by":"crossref","unstructured":"Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51(2):216\u2013226","DOI":"10.1007\/s00125-007-0886-7"},{"issue":"3","key":"2096_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0891-5849(96)02051-5","volume":"20","author":"S Lenzen","year":"1996","unstructured":"Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology and Medicine 20(3):463\u2013466","journal-title":"Free Radic Biol Med"},{"key":"2096_CR22","unstructured":"Mishra LC, BB Singh, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review.\u00a0Altern Med Rev\u00a05(4):334\u2013346"},{"issue":"3","key":"2096_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0975-9476.100168","volume":"3","author":"AA Raut","year":"2012","unstructured":"Raut AA, Rege NN, Tadvi FM, Solanki PV (2012) Experimental and clinical evaluation of Withania somnifera for its anti-inflammatory and immunomodulatory properties. Journal of Ayurveda and Integrative Medicine 3(3):139\u2013145. https:\/\/doi.org\/10.4103\/0975-9476.100168","journal-title":"J Ayurveda Integr Med"},{"key":"2096_CR24","unstructured":"Roser M, Ritchie H, Spooner F (2021) Burden of disease. Our World Data. Available at: https:\/\/ourworldindata.org\/burden-of-disease"},{"key":"2096_CR25","doi-asserted-by":"crossref","unstructured":"Rui L (2014) Energy metabolism in the liver.\u00a0Compr Physiol 4(1):177\u2013197","DOI":"10.1002\/j.2040-4603.2014.tb00548.x"},{"key":"2096_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.838027","volume":"13","author":"S Safiri","year":"2022","unstructured":"Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJM et al (2022) Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990\u20132019: results from the global burden of disease study 2019. Front Endocrinol 13:1\u201314. https:\/\/doi.org\/10.3389\/fendo.2022.838027","journal-title":"Front Endocrinol"},{"key":"2096_CR27","doi-asserted-by":"crossref","unstructured":"Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799\u2013806","DOI":"10.1038\/414799a"},{"key":"2096_CR28","doi-asserted-by":"publisher","unstructured":"Surwit RS, MN, Feinglos J Rodin A, Sutherland AE, Petro EC, Opara M, Rebuff\u00e9-Scrive, Kuhn JS\u00a0 (1988) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL\/6J mice.\u00a0Metab\u00a0Clin Exp 37(5):453\u2013460. https:\/\/doi.org\/10.1016\/0026-0495(88)90108-5.","DOI":"10.1016\/0026-0495(88)90108-5"},{"key":"2096_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2018.01857","volume":"9","author":"JS Teodoro","year":"2019","unstructured":"Teodoro JS, Nunes S, Rolo AP, Reis F, Palmeira CM (2019) Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes. Frontiers in Physiology 9:1\u201318","journal-title":"Front Physiol"},{"key":"2096_CR30","unstructured":"Udayakumar R, Kasthurirengan S, Vasudevan A, Mariashibu TS, Ganapathi A, Choi CW, Kim SC (2009) Hypoglycemic and \u03b2-cell regenerative effects of Withania somnifera in diabetic rats. Eur J Pharmacol 606(1-3)l272\u2013278"},{"key":"2096_CR31","doi-asserted-by":"publisher","first-page":"7984325","DOI":"10.1155\/2019\/7984325","volume":"2019","author":"V Venugopal","year":"2019","unstructured":"Venugopal V, Anwar V, Rajesh K (2019) Therapeutic potential of Withania somnifera in managing diabetes mellitus and its complicationS. Journal of Diabetes Research 2019:7984325. https:\/\/doi.org\/10.1155\/2019\/7984325","journal-title":"J Diab Res"},{"issue":"4","key":"2096_CR32","first-page":"472","volume":"69","author":"L Zhao","year":"2020","unstructured":"Zhao L, Li Y, Song Q, Zhang X (2020) Effects of high-fat diet and low-dose streptozotocin on type 2 diabetes in mice. Experimental Animals 69(4):472\u2013480","journal-title":"Exp Anim"}],"container-title":["Protoplasma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00709-025-02096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00709-025-02096-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00709-025-02096-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:40:29Z","timestamp":1768020029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00709-025-02096-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1007\/s00709-025-02096-4","relation":{},"ISSN":["0033-183X","1615-6102"],"issn-type":[{"value":"0033-183X","type":"print"},{"value":"1615-6102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study follows the requirements of the committee application of the Institutional Animal Care and Use Committee (IACUCs) and it approved the study design with IACUC#90-1A-0424, Pharmaceutical and Fermentation Industries Development Center (PFIDC), Egypt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}